Holen Sie sich die Stockscreener-App
40.45
1.02%
-0.415
Handel nachbörslich:
41.16
0.715
+1.77%
Schlusskurs vom Vortag:
$40.86
Offen:
$41.32
24-Stunden-Volumen:
1.39M
Relative Volume:
1.23
Marktkapitalisierung:
$2.89B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-299.62M
KGV:
-8.6719
EPS:
-4.6639
Netto-Cashflow:
$-241.73M
1W Leistung:
+6.15%
1M Leistung:
+3.52%
6M Leistung:
+30.72%
1J Leistung:
+89.79%
1-Tages-Spanne:
$39.86
$41.32
1-Wochen-Bereich:
$38.00
$42.85
52-Wochen-Spanne:
$18.53
$56.05
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Compare VERA vs VRTX, REGN, ARGX, ALNY, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VERA
Vera Therapeutics Inc
|
40.45 | 2.92B | 0 | -299.62M | -241.73M | -4.6639 |
VRTX
Vertex Pharmaceuticals Inc
|
434.30 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
763.04 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
748.25 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
330.34 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
163.81 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-11 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-10-16 | Eingeleitet | BofA Securities | Buy |
| 2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
| 2025-01-28 | Eingeleitet | Goldman | Buy |
| 2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
| 2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-12-18 | Eingeleitet | Raymond James | Outperform |
| 2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
| 2023-08-16 | Eingeleitet | Guggenheim | Buy |
| 2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
| 2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
| 2022-07-12 | Eingeleitet | JP Morgan | Overweight |
| 2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Idiopathic Membranous Nephropathy Market is Predicted to Reach USD 1 Billion by 2036 Due to Rising Therapeutic Options | DelveInsight - GlobeNewswire Inc.
BofA Initiates Coverage of Vera Therapeutics (VERA) With a Buy Rating - MSN
Vera Therapeutics Inc. (VERA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Vera Therapeutics Adds Experienced Legal Chief As Shares Trade Below Targets - Sahm
Behavioral Patterns of VERA and Institutional Flows - Stock Traders Daily
Point72 (NASDAQ: VERA) reports 1.7% holding, 1.23M shares disclosed - stocktitan.net
Big Picture: What is the next catalyst for Vera Therapeutics Inc2026 Support & Resistance & Technical Pattern Based Signals - baoquankhu1.vn
Day Trade: How cyclical is Vera Therapeutics Incs revenue stream2026 News Drivers & Technical Pattern Based Buy Signals - baoquankhu1.vn
Is Vera Therapeutics (VERA) Pricing Reflect Its DCF Upside After Recent Share Price Weakness - Sahm
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(4) - marketscreener.com
VERA SEC FilingsVera Therapeutics, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
New Vera legal chief gets 56,850 options and 42,403 RSUs - stocktitan.net
Vanguard disaggregates holdings; Vera Therapeutics (VERA) shows 0 shares reported - Stock Titan
Equity grants to Vera Therapeutics (VERA) Chief Legal Officer detailed in Form 4 - Stock Titan
Chief Legal Officer reports initial insider status at Vera Therapeutics (VERA) - stocktitan.net
Calif. Biotech Firm Vera Taps Vaxcyte Ex-GC As New CLO - Law360
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer By Investing.com - Investing.com Canada
Vera Therapeutics names Jane Wright-Mitchell as chief legal officer - Investing.com
Vera Therapeutics Appoints Jane Wright-Mitchell as Chief Legal Officer - The Manila Times
E. Ohman J or Asset Management AB Invests $2 Million in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics stock advances on promising Phase 3 data for atacicept in IgA nephropathy, boostin - AD HOC NEWS
Vera Therapeutics, Inc. (NASDAQ:VERA) Given Average Recommendation of "Moderate Buy" by Brokerages - marketbeat.com
(VERA) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Investment Firm Boosts Vera Therapeutics Holding to $41.75M in 2026News and Statistics - IndexBox
This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year - The Motley Fool
This $91 Million Investment Reflects Strong Confidence in a Biotech Firm Awaiting an FDA Ruling This Year - Bitget
Hudson Bay Capital Management Boosts Stake in Vera Therapeutics - National Today
Hudson Bay Capital Management LP Raises Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Why Vera Therapeutics Stock Is Suddenly Taking Off - TipRanks
Volume Summary: What is the next catalyst for Vera Therapeutics Inc2026 Top Decliners & Weekly Setup with High ROI Potential - baoquankhu1.vn
Deep Track Capital, LP Increases Stake in Vera Therapeutics Inc - GuruFocus
Algert Global LLC Acquires 39,235 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics (VERA) finance chief exercises options for 10,000 shares - Stock Titan
This Biotech Stock Surged 75% Last Quarter and Pulled a New $9 Million Investment - AOL.com
Eversept Partners Increases Stake in Vera Therapeutics - Intellectia AI
Assessing Vera Therapeutics (VERA) Valuation As Deerfield Ups Stake And FDA Priority Review Nears - simplywall.st
HighVista Strategies LLC Increases Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics, Inc. $VERA Shares Sold by First Light Asset Management LLC - MarketBeat
Cinctive Capital Management LP Sells 65,510 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Braidwell LP Takes Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Wall Street analysts see a 53.05% upside in Vera Therapeutics (VERA): Can the stock really move this high? - MSN
Integral Health Asset Management LLC Has $49.40 Million Stock Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Avoro Capital Advisors Reduces Stake in Vera Therapeutics - National Today
Avoro Capital Advisors LLC Sells 90,000 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision - AOL.com
Vera Therapeutics, Inc. $VERA Holdings Raised by Schroder Investment Management Group - MarketBeat
Published on: 2026-03-13 13:04:33 - baoquankhu1.vn
Aug Big Picture: What is the cash position of Vera Therapeutics Inc2026 Price Action Summary & Weekly Stock Breakout Alerts - baoquankhu1.vn
Vera Therapeutics urges expanded innovation in global kidney health on World Kidney Day - Traders Union
Wolfe Research upgrades Vera Therapeutics (VERA) - MSN
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):